Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Session Type:

Availability:

Showing session: reset

MONDAY PRESS CONFERENCE

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2
MONDAY PRESS CONFERENCE
WELCOME AND OVERVIEW OF CROI 2017
Susan P. Buchbinder
CROI Chair and University of California, San Francisco, CA, USA
Judith Currier
CROI Vice Chair and University of California, Los Angeles, CA, USA
Richard Koup
CROI Vice Chair and National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA
video audio mp3
from CROI 2017 on February 13, 2017 3:00 PM-3:45 PM
MONDAY PRESS CONFERENCE
DISCUSSION OF ORAL ABSTRACT SESSION 4 – NEW HIV DRUGS, FORMULATIONS, COMBINATIONS, AND RESISTANCE
CHAIR
Joseph Eron
University of North Carolina, Chapel Hill, NC, USA
OA4: DISCOVERY OF NOVEL POTENT HIV CAPSID INHIBITORS WITH LONG-ACTING POTENTIAL
Winston Tse
Gilead Scis, Inc, Foster City, CA, USA
OA4: RANDOMIZED TRIAL OF BICTEGRAVIR OR DOLUTEGRAVIR WITH FTC/TAF FOR INITIAL HIV THERAPY
Paul Sax
Brigham and Women's Hosp, Boston, MA, USA
OA4: PREVALENCE AND IMPACT OF PRETREATMENT DRUG RESISTANCE IN THE ANRS 12249 TASP TRIAL
Anne Derache
Africa Hlth Rsr Inst, Mtubatuba, South Africa
OA4: PHASE III SWORD 1&2: SWITCH TO DTG+RPV MAINTAINS VIROLOGIC SUPPRESSION THROUGH 48 WKS
Josep M. Llibre
Univ Hosp Germans Trias, Badalona, Barcelona, Spain
video audio mp3
from CROI 2017 on February 13, 2017 3:00 PM-3:45 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 2 of 2